February 2023

What is the latest news on Troriluzole for OCD?

What is the latest news on Troriluzole for OCD? Research⁷ results presented at the 2021 meeting of the American Psychiatric Association showed that troriluzole is effective for OCD when administered as adjunctive therapy. This means that troriluzole is effective when used with another form of treatment rather than as the sole treatment. Antidepressants approved by

What is the latest news on Troriluzole for OCD? Read More »

Did Pfizer buy Biohaven Pharmaceuticals?

Did Pfizer buy Biohaven Pharmaceuticals? Pfizer acquired all of the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, for a total transaction consideration of approximately $11.6 billion. As a result of the acquisition, Biohaven became a wholly-owned subsidiary of Pfizer. The three top institutional shareholders are Vanguard Group

Did Pfizer buy Biohaven Pharmaceuticals? Read More »

Scroll to Top